Terms: = Endocrine gland cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
34 results:
1. Retinoic acid signaling pathway in pancreatic stellate cells: Insight into the anti-fibrotic effect and mechanism.
Sun L; Zheng M; Gao Y; Brigstock DR; Gao R
Eur J Pharmacol; 2024 Mar; 967():176374. PubMed ID: 38309676
[TBL] [Abstract] [Full Text] [Related]
2. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
3. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
4. Molecular characterization of DICER1-mutated pituitary blastoma.
Nadaf J; de Kock L; Chong AS; Korbonits M; Thorner P; Benlimame N; Fu L; Peet A; Warner J; Ploner O; Shuangshoti S; Albrecht S; Hamel N; Priest JR; Rivera B; Ragoussis J; Foulkes WD
Acta Neuropathol; 2021 Jun; 141(6):929-944. PubMed ID: 33644822
[TBL] [Abstract] [Full Text] [Related]
5. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas.
Gil J; Marques-Pamies M; Jordà M; Fajardo-Montañana C; García-Martínez A; Sampedro M; Serra G; Salinas I; Blanco A; Valassi E; Sesmilo G; Carrato C; Cámara R; Lamas C; Casano-Sancho P; Alvarez CV; Bernabéu I; Webb SM; Picó A; Marazuela M; Puig-Domingo M;
Clin Endocrinol (Oxf); 2021 May; 94(5):811-819. PubMed ID: 32978826
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy.
Bagal B; Kumar R; Gaur T; Talreja V; Bonda A; Patkar N; Shetty D; Kowtal P; Subramanian PG; Gupta S; Sarin R; Hasan SK
Med Oncol; 2020 Apr; 37(5):48. PubMed ID: 32277283
[TBL] [Abstract] [Full Text] [Related]
7. ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion.
Chronopoulos A; Robinson B; Sarper M; Cortes E; Auernheimer V; Lachowski D; Attwood S; García R; Ghassemi S; Fabry B; Del Río Hernández A
Nat Commun; 2016 Sep; 7():12630. PubMed ID: 27600527
[TBL] [Abstract] [Full Text] [Related]
8. A Metabolic Inhibitory Cocktail for Grave cancers: Metformin, Pioglitazone and Lithium Combination in treatment of Pancreatic cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract] [Full Text] [Related]
9. Robot-assisted radical adrenalectomy with clamping of the vena cava for excision of a metastatic adrenal vein thrombus: a case report.
Ploumidis A; Spinoit AF; De Naeyer G; Ficarra V; Mottrie A
Int J Med Robot; 2015 Dec; 11(4):413-7. PubMed ID: 25727563
[TBL] [Abstract] [Full Text] [Related]
10. Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.
Miasaki FY; Vivaldi A; Ciampi R; Agate L; Collecchi P; Capodanno A; Pinchera A; Elisei R
J Endocrinol Invest; 2008 Aug; 31(8):724-30. PubMed ID: 18852534
[TBL] [Abstract] [Full Text] [Related]
11. Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells.
Bondioni S; Angioni AR; Corbetta S; Locatelli M; Ferrero S; Ferrante E; Mantovani G; Olgiati L; Beck-Peccoz P; Spada A; Lania AG
Exp Biol Med (Maywood); 2008 Apr; 233(4):439-46. PubMed ID: 18367633
[TBL] [Abstract] [Full Text] [Related]
12. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene.
Koh CS; Ku JL; Park SY; Kim KH; Choi JS; Kim IJ; Park JH; Oh SK; Chung JK; Lee JH; Kim WH; Kim CW; Cho BY; Park JG
Mol Cell Endocrinol; 2007 Jan; 264(1-2):118-27. PubMed ID: 17134824
[TBL] [Abstract] [Full Text] [Related]
15. High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro.
El-Metwally TH; Hussein MR; Pour PM; Kuszynski CA; Adrian TE
Cancer Biol Ther; 2005 May; 4(5):602-11. PubMed ID: 15970678
[TBL] [Abstract] [Full Text] [Related]
16. A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.
Balasubramanian S; Chandraratna RA; Eckert RL
Oncogene; 2005 Jun; 24(26):4257-70. PubMed ID: 15856029
[TBL] [Abstract] [Full Text] [Related]
17. An EGF receptor inhibitor induces rar-beta expression in breast and ovarian cancer cells.
Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
[TBL] [Abstract] [Full Text] [Related]
18. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
[TBL] [Abstract] [Full Text] [Related]
19. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.
Balasubramanian S; Chandraratna RA; Eckert RL
Carcinogenesis; 2004 Aug; 25(8):1377-85. PubMed ID: 14976133
[TBL] [Abstract] [Full Text] [Related]
20. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract] [Full Text] [Related]
[Next]
